New Role for Former FDA Commissioner Hamburg
FDA commissioner Margaret Hamburg has received praise and plaudits as she exits the Food and Drug Administration this week after six years on the job.
Former FDA commissioner Margaret A. (Peggy) Hamburg has been appointed as the next foreign secretary of the Institute of Medicine (IOM), the health arm of the National Academy of Sciences. In the part-time position, Hamburg will serve as a senior adviser on international matters to the IOM president and council and as liaison to foreign academies of medicine and science. According to NAS, Hmaburg's term began April 6 and is effective through June 30, 2019.
"Global engagement and impact are strategically important for the IOM. I am delighted that Peggy has agreed to take on this important responsibility," said IOM president Victor J. Dzau. Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides independent, objective, evidence-based advice to policymakers, health professionals, the private sector, and the public
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
FDA Approves Celltrion’s Xolair Biosimilar Omlyclo for Multiple Indications
March 10th 2025Omlyclo, a biosimilar to Xolair, is indicated for the treatment of moderate to severe persistent asthma, chronic rhinosinusitis with nasal polyps, immunoglobulin E-mediated food allergies, and chronic spontaneous urticaria.
